InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Xenon Pharmaceuticals Inc.

XENE Clue Score32
British Columbia, Canada Fiscal year ends December CIK 0001582313 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

219
Insider
Date
Role
Action
Shares
Price
Amount
Ian Mortimer
30 Sep 2026
President & CEO
Buy
30,000
$37.38
$1.12M
Thomas Patrick Kelly
30 Sep 2026
Chief Financial Officer
Buy
15,000
$37.32
$559.74K
Dawn Svoronos
1 Sep 2026
Director
Exercised, kept
5,144
$8.15
$41.92K
Christopher John Kenney
28 Aug 2026
Chief Medical Officer
Sold on a plan
700
$60.98
$42.68K
Christopher John Kenney
28 Aug 2026
Chief Medical Officer
Sold on a plan
6,368
$60.17
$383.15K
Steven Gannon
11 Aug 2026
Director
Sell
10,000
$64.06
$640.55K
Gillian Cannon
5 Jun 2026
Director
Sold on a plan
1,190
$53.14
$63.24K
Gary Patou
5 Jun 2026
Director
Sold on a plan
1,322
$53.14
$70.25K
Steven Gannon
12 May 2026
Director
Exercised, kept
3,500
$7.38
$25.83K
Ian Mortimer
13 Mar 2026
President & CEO
Sold on a plan
7,308
$55.23
$403.58K
Andrea DiFabio
13 Mar 2026
Chief Legal Officer
Sold on a plan
1,342
$55.23
$74.11K
Christopher John Kenney
13 Mar 2026
Chief Medical Officer
Sold on a plan
1,410
$55.23
$77.87K
Ian Mortimer
10 Mar 2026
President & CEO
Sold on a plan
11,269
$60.11
$677.36K
Andrea DiFabio
10 Mar 2026
Chief Legal Officer
Sold on a plan
2,607
$60.11
$156.70K
Christopher John Kenney
10 Mar 2026
Chief Medical Officer
Sold on a plan
2,771
$60.11
$166.56K
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
65,000
$62.06
$4.03M
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
61,652
$60.08
$3.70M
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
43,348
$59.26
$2.57M
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
2,449
$61.26
$150.03K
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
10,072
$60.47
$609.05K
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
12,479
$59.50
$742.50K
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
21,515
$60.49
$1.30M
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
31,694
$59.88
$1.90M
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
21,791
$58.81
$1.28M
Ian Mortimer
2 Jan 2026
President & CEO
Sold after exercise
2,062
$44.93
$92.65K
Ian Mortimer
2 Jan 2026
President & CEO
Sold after exercise
37,938
$44.40
$1.68M
Ian Mortimer
8 Dec 2025
President & CEO
Sold on a plan
2,010
$46.32
$93.10K
Ian Mortimer
8 Dec 2025
President & CEO
Sold on a plan
8,820
$45.59
$402.10K
Ian Mortimer
5 Dec 2025
President & CEO
Sold on a plan
14,375
$45.03
$647.31K
Ian Mortimer
28 Nov 2025
President & CEO
Sold on a plan
97
$45.01
$4.37K
Ian Mortimer
1 Oct 2025
President, CEO & Interim CFO
Sold after exercise
25,000
$40.16
$1.00M
Steven Gannon
5 Jun 2025
Director
Sell
3
$30.48
$91.44
Steven Gannon
14 May 2025
Director
Exercised, kept
5,144
$12.57
$64.66K
Ian Mortimer
27 Jan 2025
President & CEO
Sold after exercise
1,149
$41.07
$47.19K
Ian Mortimer
27 Jan 2025
President & CEO
Sold after exercise
15,166
$40.46
$613.62K
Ian Mortimer
24 Jan 2025
President & CEO
Sold after exercise
22,468
$40.20
$903.21K
Ian Mortimer
23 Jan 2025
President & CEO
Sold after exercise
16,217
$40.08
$649.98K
Sherry Aulin
18 Dec 2024
Chief Financial Officer
Sold after exercise
11,510
$41.19
$474.10K
Sherry Aulin
18 Dec 2024
Chief Financial Officer
Sold after exercise
7,199
$41.23
$296.81K
Gary Patou
22 Nov 2024
Director
Sold after exercise
2,040
$41.05
$83.74K
Gary Patou
22 Nov 2024
Director
Sold after exercise
2,851
$41.11
$117.20K
Elizabeth A. Garofalo
8 Mar 2024
Director
Sold after exercise
2,092
$45.69
$95.58K
Steven Gannon
7 Mar 2024
Director
Sell
2,000
$46.20
$92.40K
Steven Gannon
7 Mar 2024
Director
Sell
5,000
$46.30
$231.51K
Steven Gannon
7 Mar 2024
Director
Sell
5,000
$46.25
$231.25K
Steven Gannon
7 Mar 2024
Director
Sell
1,000
$46.45
$46.45K
Sherrington Robin
7 Mar 2024
EVP, Strategy & Innovation
Sold after exercise
6,118
$46.30
$283.26K
Sherrington Robin
7 Mar 2024
EVP, Strategy & Innovation
Sold after exercise
1,019
$46.15
$47.03K
Mohammad Azab
19 Dec 2023
Director
Exercised, kept
3,497
$9.85
$34.45K
Mohammad Azab
19 Dec 2023
Director
Exercised, kept
823
$9.85
$8.11K
Gary Patou
13 Dec 2023
Director
Sold after exercise indirect
7,598
$41.05
$311.90K
Gary Patou
13 Dec 2023
Director
Sold after exercise
3,977
$39.84
$158.44K
Gary Patou
13 Dec 2023
Director
Sold after exercise
2,303
$39.10
$90.05K
Gary Patou
13 Dec 2023
Director
Sold after exercise
5,100
$38.94
$198.59K
Dawn Svoronos
24 Aug 2023
Director
Sell
25,000
$38.70
$967.50K
Simon N. Pimstone
1 Jun 2023
Director
Sold after exercise
24,255
$38.78
$940.61K
Simon N. Pimstone
1 Jun 2023
Director
Sold after exercise
7,458
$38.97
$290.64K
Simon N. Pimstone
31 May 2023
Director
Sold after exercise
26,856
$38.69
$1.04M
Simon N. Pimstone
31 May 2023
Director
Sold after exercise
23,670
$38.81
$918.63K
Simon N. Pimstone
31 May 2023
Director
Sold after exercise
12,000
$38.53
$462.36K
Simon N. Pimstone
30 May 2023
Director
Sell
19,000
$39.90
$758.10K
Simon N. Pimstone
30 May 2023
Director
Sell
18,006
$38.63
$695.57K
Ian Mortimer
24 May 2023
President & CEO
Sold after exercise
1,407
$41.49
$58.38K
Ian Mortimer
24 May 2023
President & CEO
Sold after exercise
13,179
$41.37
$545.22K
Ian Mortimer
24 May 2023
President & CEO
Sold after exercise
17,069
$41.44
$707.34K
Christopher John Kenney
24 Mar 2023
Chief Medical Officer
Sell
700
$35.01
$24.51K
Simon N. Pimstone
7 Mar 2023
Director
Sold after exercise
8,242
$36.94
$304.46K
Simon N. Pimstone
7 Mar 2023
Director
Sold after exercise
10,990
$37.01
$406.74K
Mohammad Azab
12 Dec 2022
Director
Exercised, kept
3,086
$2.68
$8.27K
Gary Patou
25 Nov 2022
Director
Sold after exercise
1,937
$34.79
$67.39K
Gary Patou
23 Nov 2022
Director
Sell
2,057
$34.33
$70.61K
Sherry Aulin
2 Sep 2022
Chief Financial Officer
Sold after exercise
15,355
$39.57
$607.60K
Sherrington Robin
1 Sep 2022
EVP, Strategy & Innovation
Sold after exercise
8,776
$38.80
$340.51K
Sherrington Robin
1 Sep 2022
EVP, Strategy & Innovation
Sold after exercise
35,103
$38.03
$1.33M
Sherrington Robin
31 Aug 2022
EVP, Strategy & Innovation
Sold after exercise
21,352
$38.57
$823.55K
Simon N. Pimstone
16 Aug 2022
Director
Sell
20,000
$38.87
$777.40K
Simon N. Pimstone
16 Aug 2022
Director
Sell
32,058
$38.29
$1.23M
Simon N. Pimstone
15 Aug 2022
Director
Sell
33,942
$37.76
$1.28M
Simon N. Pimstone
12 Aug 2022
Director
Sell
1,000
$39.15
$39.15K
Simon N. Pimstone
12 Aug 2022
Director
Sell
47,000
$38.60
$1.81M
Simon N. Pimstone
12 Aug 2022
Director
Sell
43,135
$37.91
$1.64M
James R. Empfield
12 Aug 2022
EVP, Drug Discovery
Sold after exercise
21,875
$38.68
$846.13K
James R. Empfield
12 Aug 2022
EVP, Drug Discovery
Sold after exercise
35,868
$38.08
$1.37M
Simon N. Pimstone
8 Mar 2022
Director
Sell
2,500
$30.50
$76.25K
Simon N. Pimstone
8 Mar 2022
Director
Sell
2,500
$30.55
$76.38K
Simon N. Pimstone
8 Mar 2022
Director
Sell
2,500
$30.20
$75.50K
Simon N. Pimstone
8 Mar 2022
Director
Sell
2,500
$30.10
$75.25K
Simon N. Pimstone
8 Mar 2022
Director
Sell
2,500
$3.80
$9.50K
Simon N. Pimstone
8 Mar 2022
Director
Sell
2,051
$30.60
$62.76K
James R. Empfield
7 Mar 2022
EVP, Drug Discovery
Sold after exercise
31,048
$30.54
$948.21K
James R. Empfield
7 Mar 2022
EVP, Drug Discovery
Sold after exercise
1,805
$30.62
$55.27K
Simon N. Pimstone
7 Mar 2022
Director
Sold after exercise
2,500
$30.55
$76.38K
Simon N. Pimstone
7 Mar 2022
Director
Sold after exercise
7,500
$30.50
$228.75K
Simon N. Pimstone
7 Mar 2022
Director
Sold after exercise
2,500
$30.52
$76.30K
Simon N. Pimstone
7 Mar 2022
Director
Sold after exercise
4,516
$30.44
$137.47K
Simon N. Pimstone
7 Mar 2022
Director
Sold after exercise
4,516
$30.45
$137.51K
Simon N. Pimstone
7 Mar 2022
Director
Sold after exercise
4,517
$30.49
$137.72K
Simon N. Pimstone
7 Mar 2022
Director
Sold after exercise
5,037
$30.60
$154.13K
James R. Empfield
4 Mar 2022
EVP, Drug Discovery
Sold after exercise
18,315
$30.79
$563.92K
Sherrington Robin
4 Mar 2022
EVP, Strategy & Innovation
Sold after exercise
5,000
$30.23
$151.15K
Sherrington Robin
4 Mar 2022
EVP, Strategy & Innovation
Sold after exercise
5,000
$31.05
$155.25K
Sherrington Robin
4 Mar 2022
EVP, Strategy & Innovation
Sold after exercise
5,000
$30.15
$150.75K
Sherrington Robin
4 Mar 2022
EVP, Strategy & Innovation
Sold after exercise
6,710
$30.56
$205.06K
Simon N. Pimstone
4 Mar 2022
Director
Sold after exercise
4,793
$30.56
$146.47K
Simon N. Pimstone
4 Mar 2022
Director
Sold after exercise
4,532
$30.66
$138.95K
Christopher John Kenney
21 Jan 2022
Chief Medical Officer
Buy
700
$28.81
$20.17K
Mohammad Azab
15 Dec 2021
Director
Exercised, kept
3,086
$3.67
$11.33K
Gary Patou
8 Dec 2021
Director
Exercised, kept
2,057
$3.67
$7.55K
Seggern Christopher Von
6 Dec 2021
Chief Commercial Officer
Buy
4,000
$24.40
$97.60K
Simon N. Pimstone
15 Nov 2021
Director
Sell
17,557
$31.33
$550.06K
Sherrington Robin
28 May 2021
EVP, Strategy & Innovation
Sold after exercise
2,912
$18.81
$54.77K
Sherrington Robin
28 May 2021
EVP, Strategy & Innovation
Sold after exercise
3,155
$18.81
$59.35K
Frank A Holler
27 May 2021
Director
Sold after exercise
8,485
$18.68
$158.50K
Frank A Holler
27 May 2021
Director
Sold after exercise
2,579
$18.69
$48.20K
Simon N. Pimstone
24 May 2021
CEO
Exercised, kept
22,633
$3.76
$85.10K
Michael R Hayden
18 May 2021
Director
Exercised, kept
3,500
$3.85
$13.48K
Michael M Tarnow
18 May 2021
Director
Exercised, kept
5,144
$3.67
$18.88K
Michael M Tarnow
18 May 2021
Director
Exercised, kept
1,028
$3.67
$3.77K
Michael M Tarnow
18 May 2021
Director
Exercised, kept
2,057
$3.87
$7.96K
Michael R Hayden
18 Feb 2021
Director
Exercised, kept indirect
30,864
$2.68
$82.72K
Michael R Hayden
18 Feb 2021
Director
Exercised, kept indirect
10,288
$3.67
$37.76K
Michael R Hayden
16 Feb 2021
Director
Exercised, kept
5,144
$2.68
$13.79K
Mohammad Azab
15 Dec 2020
Director
Exercised, kept
3,086
$3.76
$11.60K
Gary Patou
28 Oct 2020
Director
Exercised, kept
2,057
$3.76
$7.73K
Michael M Tarnow
28 Oct 2020
Director
Exercised, kept
5,144
$3.76
$19.34K
Michael M Tarnow
28 Oct 2020
Director
Exercised, kept
5,144
$3.76
$19.34K
Michael M Tarnow
9 Jun 2020
Director
Exercised, kept
5,144
$3.52
$18.11K
Simon N. Pimstone
1 Jun 2020
CEO
Sell
3,000
$14.43
$43.29K
Sherrington Robin
1 Jun 2020
EVP, Strategy & Innovation
Exercised, kept
8,230
$3.56
$29.30K
Simon N. Pimstone
29 May 2020
CEO
Sell
5,000
$13.99
$69.95K
Frank A Holler
29 May 2020
Director
Exercised, kept
3,086
$3.56
$10.99K
Simon N. Pimstone
26 May 2020
CEO
Exercised, kept
6,172
$3.56
$21.97K
Mohammad Azab
16 Dec 2019
Director
Exercised, kept
3,086
$3.56
$10.99K
Gary Patou
4 Dec 2019
Director
Exercised, kept
2,057
$3.56
$7.32K
Michael M Tarnow
21 Nov 2019
Director
Exercised, kept
2,057
$3.51
$7.22K
Michael M Tarnow
21 Nov 2019
Director
Exercised, kept
5,144
$3.56
$18.31K
Frank A Holler
20 Sep 2019
Director
Sell
5,206
$9.39
$48.88K
Simon N. Pimstone
20 Sep 2019
CEO
Sell
10,395
$9.51
$98.86K
Frank A Holler
19 Sep 2019
Director
Sell
7,600
$9.27
$70.45K
Frank A Holler
18 Sep 2019
Director
Sell
4,368
$9.28
$40.54K
Frank A Holler
17 Sep 2019
Director
Sell
5,069
$9.32
$47.24K
Simon N. Pimstone
17 Sep 2019
CEO
Exercised, kept
12,345
$3.38
$41.73K
Simon N. Pimstone
17 Sep 2019
CEO
Exercised, kept
9,259
$3.07
$28.43K
Simon N. Pimstone
17 Sep 2019
CEO
Exercised, kept
36,008
$3.70
$133.23K
Mohammad Azab
13 Sep 2019
Director
Sell
23
$9.31
$214.18
Sherrington Robin
12 Sep 2019
EVP, Strategy & Innovation
Exercised, kept
6,172
$3.07
$18.95K
Frank A Holler
12 Sep 2019
Director
Exercised, kept
25,720
$3.00
$77.16K
Frank A Holler
12 Sep 2019
Director
Exercised, kept
3,086
$3.07
$9.47K
Frank A Holler
12 Sep 2019
Director
Exercised, kept
3,086
$3.70
$11.42K
Michael M Tarnow
21 May 2019
Director
Exercised, kept
2,057
$3.21
$6.60K
Michael R Hayden
19 Mar 2019
Director
Exercised, kept indirect
20,576
$3.38
$69.55K
Gary Patou
14 Dec 2018
Director
Exercised, kept
2,057
$3.07
$6.31K
Charles J. Cohen
11 Dec 2018
VP, Biology
Exercised, kept
4,115
$3.07
$12.63K
Mohammad Azab
6 Dec 2018
Director
Exercised, kept
3,086
$3.07
$9.47K
Mohammad Azab
21 Jun 2018
Director
Exercised, kept
10,288
$3.70
$38.07K
Michael M Tarnow
21 Jun 2018
Director
Exercised, kept
5,144
$3.07
$15.79K
Michael M Tarnow
21 Jun 2018
Director
Exercised, kept
2,057
$3.66
$7.53K
Michael M Tarnow
21 Jun 2018
Director
Exercised, kept
5,144
$3.70
$19.03K
Gary Patou
14 Jun 2018
Director
Exercised, kept
8,230
$3.70
$30.45K
Sherrington Robin
15 Mar 2018
EVP Bus. & Corp. Development
Exercised, kept
3,086
$3.77
$11.63K
Frank A Holler
14 Mar 2018
Director
Exercised, kept
3,086
$3.77
$11.63K
Simon N. Pimstone
12 Mar 2018
CEO
Exercised, kept
10,288
$3.77
$38.79K
Charles J. Cohen
12 Feb 2018
VP, Biology
Exercised, kept
26,748
$3.71
$99.24K
Mohammad Azab
15 Nov 2017
Director
Buy
15,000
$2.22
$33.28K
Mohammad Azab
22 Sep 2017
Director
Buy
8,000
$2.95
$23.60K
Mohammad Azab
21 Sep 2017
Director
Buy
2,000
$2.95
$5.90K
Raymond Winquist
18 Aug 2017
Head, Translational Research
Buy
1,000
$3.00
$3.00K
Mohammad Azab
18 Aug 2017
Director
Buy
6,312
$2.90
$18.30K
Mohammad Azab
17 Aug 2017
Director
Buy
23
$2.65
$60.95
Bvf Partners L P/Il
15 Aug 2017
10% owner
Buy
7,429
$2.41
$17.92K
Bvf Partners L P/Il
15 Aug 2017
10% owner
Buy
11,429
$2.41
$27.57K
James R. Empfield
15 Aug 2017
SVP, Drug Discovery
Buy
10,000
$2.48
$24.82K
Michael R Hayden
14 Aug 2017
Director
Buy
15,000
$2.75
$41.25K
Dawn Svoronos
14 Aug 2017
Director
Buy
50,000
$2.82
$140.77K
Bvf Partners L P/Il
14 Aug 2017
10% owner
Buy
13,337
$2.70
$36.06K
Bvf Partners L P/Il
14 Aug 2017
10% owner
Buy
28,007
$2.70
$75.72K
Steven Gannon
11 Aug 2017
Director
Buy
15,000
$2.82
$42.27K
Simon N. Pimstone
10 Aug 2017
President & CEO
Buy
6,000
$2.90
$17.40K
Richard H Scheller
10 Aug 2017
Director
Buy
7,000
$2.85
$19.95K
Ian Mortimer
10 Aug 2017
CFO & COO
Buy indirect
10,000
$2.90
$29.00K
Ian Mortimer
10 Aug 2017
CFO & COO
Buy
5,000
$2.85
$14.23K
Gary Patou
10 Aug 2017
Director
Buy indirect
7,500
$2.78
$20.84K
Gary Patou
8 Aug 2017
Director
Buy indirect
5,000
$3.00
$15.00K
Bvf Partners L P/Il
27 Jun 2017
10% owner
Buy
8,496
$4.00
$33.98K
Bvf Partners L P/Il
27 Jun 2017
10% owner
Buy
30,170
$4.00
$120.68K
Bvf Partners L P/Il
27 Jun 2017
10% owner
Buy
46,795
$4.00
$187.18K
Bvf Partners L P/Il
22 Jun 2017
10% owner
Buy
854
$4.00
$3.42K
Bvf Partners L P/Il
22 Jun 2017
10% owner
Buy
2,884
$4.00
$11.54K
Bvf Partners L P/Il
22 Jun 2017
10% owner
Buy
4,525
$4.00
$18.10K
Bvf Partners L P/Il
21 Jun 2017
10% owner
Buy
1,362
$4.00
$5.45K
Bvf Partners L P/Il
21 Jun 2017
10% owner
Buy
4,406
$4.00
$17.62K
Bvf Partners L P/Il
21 Jun 2017
10% owner
Buy
6,380
$4.00
$25.52K
Bvf Partners L P/Il
19 Jun 2017
10% owner
Buy
357
$3.85
$1.37K
Bvf Partners L P/Il
19 Jun 2017
10% owner
Buy
1,271
$3.85
$4.89K
Bvf Partners L P/Il
19 Jun 2017
10% owner
Buy
1,967
$3.85
$7.57K
Michael M Tarnow
19 Jun 2017
Director
Exercised, kept
1,028
$3.51
$3.61K
Bvf Partners L P/Il
16 Jun 2017
10% owner
Buy
1,064
$3.85
$4.10K
Bvf Partners L P/Il
16 Jun 2017
10% owner
Buy
3,873
$3.85
$14.91K
Bvf Partners L P/Il
16 Jun 2017
10% owner
Buy
6,097
$3.85
$23.47K
Bvf Partners L P/Il
15 Jun 2017
10% owner
Buy
1,160
$3.84
$4.45K
Bvf Partners L P/Il
15 Jun 2017
10% owner
Buy
3,845
$3.84
$14.75K
Bvf Partners L P/Il
15 Jun 2017
10% owner
Buy
6,774
$3.84
$25.99K
Bvf Partners L P/Il
7 Jun 2017
10% owner
Buy
20,594
$3.85
$79.31K
Bvf Partners L P/Il
7 Jun 2017
10% owner
Buy
73,749
$3.85
$284.02K
Bvf Partners L P/Il
7 Jun 2017
10% owner
Buy
113,446
$3.85
$436.90K
Bvf Partners L P/Il
6 Jun 2017
10% owner
Buy
913
$3.75
$3.42K
Bvf Partners L P/Il
6 Jun 2017
10% owner
Buy
53,260
$3.75
$199.73K
Bvf Partners L P/Il
6 Jun 2017
10% owner
Buy
96,736
$3.75
$362.76K
Sherrington Robin
12 May 2017
SVP Bus. & Corp. Development
Exercised, kept
2,057
$3.21
$6.60K
Michael R Hayden
14 Mar 2017
Director
Exercised, kept indirect
3,086
$3.56
$10.99K
Michael R Hayden
14 Mar 2017
Director
Exercised, kept indirect
4,629
$3.07
$14.21K
Michael R Hayden
14 Mar 2017
Director
Exercised, kept indirect
4,115
$3.77
$15.51K
Michael R Hayden
14 Mar 2017
Director
Exercised, kept
5,144
$3.67
$18.88K
Michael R Hayden
14 Mar 2017
Director
Exercised, kept
25,720
$3.76
$96.71K
Michael R Hayden
14 Mar 2017
Director
Exercised, kept
18,004
$3.70
$66.61K
Frank A Holler
15 Dec 2016
Director
Sell
30,000
$7.85
$235.50K
Michael M Tarnow
12 Dec 2016
Director
Exercised, kept
14,403
$3.21
$46.23K
Gary Patou
6 Dec 2016
Director
Exercised, kept
12,345
$3.21
$39.63K
Mohammad Azab
1 Dec 2016
Director
Exercised, kept
12,345
$3.21
$39.63K

What was left out

Form 4 filings counted 258
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 64
Sales at will 33
Transactions with no price 0
Shares from compensation/vesting 4,426,192
Sales filed before the plan box existed 23
History held since 6 Nov 2014